Cargando…
Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
OBJECTIVES: The aim of this study is to present the clinical, oncological, and functional results of locally aggressive benign bone tumors treated with extended intralesional curettage without the use of adjuvant in a tertiary orthopedic oncology center. METHOD: A total of 172 patients treated with...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036382/ https://www.ncbi.nlm.nih.gov/pubmed/35481245 http://dx.doi.org/10.1177/20503121221094199 |
_version_ | 1784693512360427520 |
---|---|
author | Yenigül, Ali Erkan Sofulu, Ömer Erol, Bülent |
author_facet | Yenigül, Ali Erkan Sofulu, Ömer Erol, Bülent |
author_sort | Yenigül, Ali Erkan |
collection | PubMed |
description | OBJECTIVES: The aim of this study is to present the clinical, oncological, and functional results of locally aggressive benign bone tumors treated with extended intralesional curettage without the use of adjuvant in a tertiary orthopedic oncology center. METHOD: A total of 172 patients treated with surgical curettage and high-speed burrs for the diagnosis of aneurysmal bone cyst, giant cell tumor, osteoblastoma, chondroblastoma, and chondromyxoid fibroma were included in the study. Demographic, radiological, and clinical data of the patients were analyzed. RESULTS: One-hundred seventy two patients (101 (59%) female and 71 (41%) male) with a mean age of 23 years (6–84). The mean follow-up period was 48 months (18–108). In the study, a total of 8 (4.6%) patients had postoperative complications, 17 (9.9%) patients had recurrence in the postoperative period. Diameter greater than 5 cm was found to be a risk factor for recurrence (p < 0.004). The probability of developing complications was found to be significantly higher in patients with recurrence (p < 0.001). There was no significant relationship between recurrence and age, tumor type, and tumor stage. CONCLUSION: Successful treatment results can be obtained with extended surgical curettage, high-speed burr, and cauterization without the use of chemical adjuvants in locally aggressive bone tumors. |
format | Online Article Text |
id | pubmed-9036382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-90363822022-04-26 Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants Yenigül, Ali Erkan Sofulu, Ömer Erol, Bülent SAGE Open Med Original Research Article OBJECTIVES: The aim of this study is to present the clinical, oncological, and functional results of locally aggressive benign bone tumors treated with extended intralesional curettage without the use of adjuvant in a tertiary orthopedic oncology center. METHOD: A total of 172 patients treated with surgical curettage and high-speed burrs for the diagnosis of aneurysmal bone cyst, giant cell tumor, osteoblastoma, chondroblastoma, and chondromyxoid fibroma were included in the study. Demographic, radiological, and clinical data of the patients were analyzed. RESULTS: One-hundred seventy two patients (101 (59%) female and 71 (41%) male) with a mean age of 23 years (6–84). The mean follow-up period was 48 months (18–108). In the study, a total of 8 (4.6%) patients had postoperative complications, 17 (9.9%) patients had recurrence in the postoperative period. Diameter greater than 5 cm was found to be a risk factor for recurrence (p < 0.004). The probability of developing complications was found to be significantly higher in patients with recurrence (p < 0.001). There was no significant relationship between recurrence and age, tumor type, and tumor stage. CONCLUSION: Successful treatment results can be obtained with extended surgical curettage, high-speed burr, and cauterization without the use of chemical adjuvants in locally aggressive bone tumors. SAGE Publications 2022-04-22 /pmc/articles/PMC9036382/ /pubmed/35481245 http://dx.doi.org/10.1177/20503121221094199 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Yenigül, Ali Erkan Sofulu, Ömer Erol, Bülent Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants |
title | Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants |
title_full | Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants |
title_fullStr | Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants |
title_full_unstemmed | Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants |
title_short | Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants |
title_sort | treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036382/ https://www.ncbi.nlm.nih.gov/pubmed/35481245 http://dx.doi.org/10.1177/20503121221094199 |
work_keys_str_mv | AT yenigulalierkan treatmentoflocallyaggressivebenignbonetumorsbymeansofextendedintralesionalcurettagewithoutchemicaladjuvants AT sofuluomer treatmentoflocallyaggressivebenignbonetumorsbymeansofextendedintralesionalcurettagewithoutchemicaladjuvants AT erolbulent treatmentoflocallyaggressivebenignbonetumorsbymeansofextendedintralesionalcurettagewithoutchemicaladjuvants |